Deficiency of insulin signaling permits unregulated adipose tissue lipolysis, leading to dyslipidemia and the ectopic deposition of lipids in non-adipose tissues such as the liver, further causing hepatic steatosis and exacerbating systemic insulin resistance [28]. The gene discussed is INS; the disease is fatty liver disease.